Navigation Links
Wolters Kluwer Health's New Forecasting Service Models Pharma's Future
Date:6/29/2009

inThought offers market data, analysis and forecasting from a single source

BRIDGEWATER, N.J., June 29 /PRNewswire/ -- Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry, today introduced Wolters Kluwer Health inThought(TM), a new market research service that offers an array of pharmaceutical forecasting capabilities. inThought was developed to help financial analysts, health care suppliers and drug makers understand where developmental drugs, medical devices, and therapies are positioned today and where they are likely headed in the future.

inThought is among the first of a new generation of research services that can deliver data, analysis and forecasting from a single source, an approach that is both cost effective and helps streamline the market research process. inThought integrates Wolters Kluwer Health's trusted clinical, prescription, managed markets, and patient information -- recognized to be of the highest quality in the industry -- together with the keen insight and forecasting abilities developed by a team of highly skilled individuals including researchers, analysts and physicians.

"With research headcounts down, there's a fundamental shift in the way analysts and pharma customers want their research delivered," said Ben Weintraub, Director of Research, Wolters Kluwer Health inThought. "Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important."

Customers now have all of the tools they need from a single, independent source to aid them in making more efficient decisions about their products, markets and competitors. inThought's progressive approach benefits from the wealth of knowledge and experience provided by Wolters Kluwer Health Pharma Solutions' professional data analysts, a distinction that helps identify trends as they unfold.

"With inThought, we alleviate one of the main issues with traditional pharma research products: once you buy it, you still have to make time to use it and understand the implications for your product," said Mark Spiers, President and CEO, Wolters Kluwer Health, Pharma Solutions. "This approach provides an edge for understanding the future market for a pharmaceutical brand or medical device."

inThought research and analysis is available to customers through products such as research alerts geared toward specific customer requirements; subscriptions to a powerful, Web-based drug pipeline database that integrates inThought forecasts with detailed monitoring of drug development programs around the world; regular conference calls to connect customers with medical experts providing the physician perspective; revenue forecasts and probability of approval models for 300+ drugs in development; syndicated research reports that delve deep into specific markets; and custom research projects and counsel designed to meet individual customer needs.

For more information about Wolters Kluwer Health inThought, visit www.in-thought.com.

About Wolters Kluwer Health

Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(R); electronic information providers, such as Ovid, UpToDate(R), Medi-Span(R) and ProVation(R) Medical; and pharmaceutical information providers such as Adis International and Source(R).

Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of euro 3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

    Contact:  Tom Kivett
              Kivett & Company Communications
              (212) 727-2935
              tkivett@kivettandco.com


'/>"/>
SOURCE Wolters Kluwer Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wolters Kluwer Health Customer Service Organization Awarded Center of Excellence Certification
2. Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman
3. Wolters Kluwer Healths Unique Prescription Data Tapped by FDA in Effort to Advance Drug Safety
4. Wolters Kluwer Appoints Robert Becker as President and CEO Wolters Kluwer Health; and Stacey Caywood as President and CEO Wolters Kluwer Law & Business (U.S.)
5. Wolters Kluwer Health Appoints Scott Lubeck Vice President, Technology of its Professional & Education Unit
6. Wolters Kluwer Health Appoints Susan Driscoll as Executive Vice President & General Manager of the Books Business of its Professional & Education Unit
7. Wolters Kluwer Health Introduces Formulary Facts(TM), a Formulary Analytics Tool that Sets the Standard for Accuracy and Ease-of-Use
8. HealthSource of Chicago: New Techniques for Back Pain Relief in Chicago
9. iHealthSpot, Inc Named Winner in the 2009 STEVIE' AWARDS (American Business Awards)
10. HealthSouth Comments on Civil Litigation
11. Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , ... March 24, 2017 , ... The Radiology ... Quest Awards . The annual awards, now in their 12th year, are among the ... the winners. , In 2016, the awards were retooled to recognize achievements in both ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred ... 2017. This sacred and spiritual journey during the Summer Solstice will also ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... In 2016 ... now estimates that there could be four million Zika-related cases in the Americas within ... with numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017   The Accreditation Council for Medical ... in the pharmaceutical industry has appointed Dr. ... newly formed scientific advisory board. Dr. Chin will ... first ever medical affairs think tank within the ... the ACMA, please visit  www.medicalaffairsspecialist.org .  Connect ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
(Date:3/24/2017)... , March 24, 2017 Today ... Equipment stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. ... Inc. (NASDAQ: SSH ). These companies are part ... prior gains on Thursday, March 23 rd , 2017, with ... while shares of health care companies in the S&P 500 ...
Breaking Medicine Technology: